LIVESTREAM | REGISTER | ADD TO CALENDAR | PERMALINK
On Tuesday, 8 September 2026, the Atlantic Council‘s Cyber Statecraft Initiative hosted a hybrid public discussion ‘Data Governance for AI and Healthcare: From Washington to Beijing‘ at Atlantic Council Headquarters in Washington DC.
AI is reshaping drug discovery, clinical trials, precision medicine and healthcare delivery, but building and deploying it at scale depends on high-quality data, computing power, energy and digital infrastructure, as well as on navigating fast-moving regulatory requirements. Part of the Cyber Statecraft Initiative’s Data Rules Project, the session brought together leaders from the biosciences industry, government and academia to ask how healthcare and pharmaceutical companies can build AI at scale while protecting patient trust, privacy, security and sustainability, and to weigh how the United States, China and other major technology markets are approaching these questions, and what their differing policy and infrastructure choices mean for pharmaceutical research and development, patient outcomes and US competitiveness.
WELCOME REMARKS
Jenna Ben-Yehuda – Executive Vice President, Atlantic Council
SPEAKERS
Ranjit Kumble – Vice President, Trusted AI, Pfizer
Stephen Moon – Global Public Sector Chief Technology Officer (CTO), Snowflake
Daria Bahrami – Head of Policy, Dreadnode
Gil Alterovitz – Associate Professor, Harvard Medical School; President, Presidential Innovation Fellows Foundation
MODERATORS
Graham Brookie – Vice President, Atlantic Council Technology Programs, Atlantic Council
Trey Herr – Assistant Professor, School of International Service, American University; Nonresident Senior Fellow, Cyber Statecraft Initiative, Atlantic Council
CLOSING REMARKS
Safa Shahwan Edwards – Director, Cyber Statecraft Initiative, Atlantic Council
#ACCyber #AI #HealthData #DataGovernance
